After Rejection, Tenapanor for Kidney Disease Faces FDA's Outside Experts

(MedPage Today) -- Does tenapanor hydrochloride (Ibsrela) produce a clinically meaningful effect on serum phosphorus for patients with chronic kidney disease (CKD) on dialysis? That question will be front and center for independent advisors to...
Source: MedPage Today Public Health - Category: American Health Source Type: news